Honda
Summary
NHTSA campaign 26V365: Honda recalled for a safety defect. Failure of rear suspension components, such as the rear control arm, can cause a loss of vehicle handling and control, i
Details
Source
nhtsa
External ID
26V365
Action Date
2026-06-05
Status
Ongoing
Category
vehicle
Product Description
American Honda Motor Company (Honda) is recalling certain 2016-2022 Honda Pilot, 2017-2023 Ridgeline, 2019-2023 Passport, and 2014-2020 Acura MDX vehicles that were sold in Connecticut, Delaware, District of Columbia, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont, Virginia, West Virginia, or Wisconsin. The rear subframe may corrode at the suspension mounting points, which can result in rear suspension component failure.
Company
Context & Analysis
Honda has 82 FDA actions in our database.
Frequently Asked Questions
How often does Honda have FDA actions?
Honda has 82 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle